The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Guideline for opioid therapy and chronic noncancer pain
Open accessAbstract
Chronic noncancer pain includes any painful condition that persists for at least three months and is not associated with malignant disease.[1][1] According to seven national surveys conducted between 1994 and 2008, 15%–19% of Canadian adults live with chronic noncancer pain.[2][2] Chronic
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the time of TPS referral, patients in the ACT group were taking high doses of opioid medication—well above the 90 mg MED maximum upper limit recommended by the 2017 Canadian guideline for opioids for chronic non-cancer pain.45”
From Acceptance and Commitment Therapy to manage pain and opioid use after major surgery: Preliminary outcomes from the Toronto General Hospital Transitional Pain Service (2017) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Self-citationAndrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Self-citationAndrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,366
Self-citationOpioid Prescriptions for Chronic Pain and Overdose
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta‐Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,265
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196
Self-citationA synthesis of oral morphine equivalents (OME) for opioid utilisation studies
Nielsen, S., Degenhardt, L. J., Hoban, B., & Gisev, N. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3945 · Cited by 617
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6501e1er · Cited by 549
Flagged first, then by citations
Research works printed but not linked: 3
- Merskey H, Bogduk N; Task Force on Taxonomy of the International Associa- tion for the Study of Pain. Classification of chronic pain, second edition (revised). Seattle (WA): International Association for the Study of Pain; 1994.
- New York City Department of Health and Mental Hygiene. Preventing misuse of prescription opioid drugs. City Health Information 2011;30:23-30.
- College endorses the US Centers for Disease Control and Prevention's guide- lines for prescribing opioids for chronic pain [media release]. Halifax (NS): Col- lege of Physicians & Surgeons of Nova Scotia; 2016. Available: www.cpsns.ns. ca/News/Press-Releases/Details/ArticleId/266/College-Endorses-CDC-Guidelines -for-Prescribing-Opioids-for-Chronic-Pain (accessed 2017 Mar. 11).
Cited by
Sorted by citations
Items 601–700 of 707
Herx, L. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.71591
Singovski, S., Pautex, S., & Escher, M. (2022) · JMIG · doi:10.53738/revmed.2022.18.787.1238
Girard, T., Dayan, N., Wilson, M. G., Harris, M. T. H., El‐Messidi, A., Gosselin, S., FLEISZER, D. M., Bonnici, A., Villeneuve, É., Lee, T. C., et al. (2022) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635221110153
“For example, the Canadian Medical Association has published guidelines that emphasize optimizing nonopioid pharmacotherapy and nonpharmacologic therapy for patients with pain and restricting opioid doses to less than 50 morphine milligram equivalents (MME) daily when initiating opioid therapy.(6) Similarly, the CDC re…”
BackgroundResponse to “Winner of the Ronald Melzack — Canadian Journal of Pain 2021 Paper of the Year Award”
Busse, J. W., Juurlink, D. N., & Buckley, D. N. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2108775
Self-citationClinical Assessment of Patients to Decrease Risk
Schweiger, V., Parolini, M., Martini, A., & Polati, E. (2022) · doi:10.1002/9781119757306.ch4
Mukhida, K., Sedighi, S., & Hart, C. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2123308
Prescription des opioïdes en médecine générale pour les douleurs chroniques non cancéreuses
Nicollier, L., Pasquier, S. D., Berger, J., & Gouveia, A. (2022) · JMIG · doi:10.53738/revmed.2022.18.796.1761
A regional approach to reduce postoperative opioid prescribing in Ontario, Canada
Jackson, T. D., Maeda, A., Beath, T., Ahmad, N., Arsenault, P. P., Jia, H., Lam, J. M. C., & Schramm, D. (2022) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzac077
Prescriptions pour les complications courantes des lésions de la moelle épinière
McColl, M. A., Gupta, S., McColl, A., & Smith, K. (2022) · Canadian Family Physician · doi:10.46747/cfp.6812889
Deng, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-12998-8_10
Contemporary prescription opioid use for pain among Canadian Armed Forces Veterans in Ontario
Harrison, L. D., Kitchen, S. A., Whitehead, M., Mahar, A. L., Busse, J. W., & Gomes, T. (2023) · Journal of Military Veteran and Family Health · doi:10.3138/jmvfh-2022-0027
Self-citationWu, P.-C., Tsai, S., Chen, T.-J., & Chen, M. (2023) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_14_23
Kendzerska, T., Malhotra, A., Gershon, A. S., Povitz, M., McIsaac, D. I., Aaron, S. D., Bryson, G. L., Talarico, R., Godbout, M., Tanuseputro, P., et al. (2023) · Frontiers in Sleep · doi:10.3389/frsle.2023.1161857
Risks of opioid use in the elderly with persistent pain
Lapka, M. (2023) · Klinická farmakologie a farmacie · doi:10.36290/far.2023.013
Checking Each Other’s Math: Is It Possible Without a Single Standard for Opioid Dose Equivalence?
Edmonds, K. P., & Atayee, R. S. (2023) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2023.2240303
Turner, S., Allen, V. M., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.013
Desafíos en el manejo analgésico perioperatorio del paciente oncológico usuario de opioides
Palma, A. P., & Parada, C. N. V. (2023) · Revista Chilena de Anestesia · doi:10.25237/revchilanestv52n8-08
Mesquita, G., Pedro, A., Moutinho, R., Sampaio, R., & Antunes, F. J. R. (2023) · Revista Dor · doi:10.24875/dor.m23000029
Managing Pain in Patients on Long-Term Opioids
Sandbrink, F. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197649176.003.0031
Actualización farmacológica de los analgésicos opioides
Rodríguez, M. T. P., Nadal, N. R., & Mora, R. M. (2024) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2024.05.004
Tratamiento del dolor persistente, evidencias
Dalmau-Roig, A., Castaño-Asins, J. R., & Morral, A. (2024) · Formacion Medica Continuada En Atencion Primaria · doi:10.1016/j.fmc.2024.05.003
Claves para uso racional de opioides en el tratamiento del dolor persistente
Canales, L. D. M. V., Dalmau-Roig, A., & Obach, A. (2024) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2024.05.005
Emary, P. C., & Stuber, K. J. (2024) · PubMed Central
Nielsen, S. H., Andersen, M. K. K., Søndergaard, J., & Pedersen, L. B. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102821
Pharmacotherapy of chronic noncancer pain in adults
Pjević, M. (2024) · Galenika Medical Journal · doi:10.5937/galmed2410035p
Navigating opioid use in chronic noncancer pain conditions: A case series on pseudoaddiction
Dhagudu, N. K., Kaur, M., George, A. B., & Ambekar, A. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_69_24
“[7,8] Due to the risks of addiction and overdoses, systematic assessments like the USFDA’s Risk Evaluation and Mitigation Strategies are crucial, which include patient education about risks and prescriber guidelines on safe use.”
Choosing Wisely in Physical Medicine and Rehabilitation
Neferu, R., Fortin, C. D., Guo, M., Robinson, L. R., & Bateman, E. A. (2024) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000002599
Kellam, H., Cooke, C., Smith, D. L., & Haight, P. (2024) · MedEdPublish · doi:10.12688/mep.20492.1
Shimada, N., Igarashi, T., Inami, K., Kurosaki, F., Shimizu, A., & Tamba, K. (2024) · Palliative Care Research · doi:10.2512/jspm.19.293
Wilson, L. E., Knaggs, R., Avery, A. J., Thornley, T., Moss, J., Baamer, R. M., & Boyd, M. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001246
“…levels of opioid prescribing have updated clinical guidelines to avoid or limit the use of opioids in many painful conditions, especially in CNCP. 13,21,46,51 41, 43 The United Kingdom National Health The Prescribed Opioids Difficulties Scale (PODS) is a survey tool developed to assess recent…”
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia
St‐Jean, I., Hachemi, D., Friciu, M., Forest, J., Bélliveau, M., Williamson, D. R., & Leclair, G. (2025) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2024-004177
“One study demonstrated the stability of dexmedetomidine hydrochloride 4, 8, 12 and 20 µ g/ mL stored in polyvinyl chloride (PVC) bags at 23°C for 48 hours, the total duration of the study.”
Panagiotoglou, D., Peterson, S., Lavergne, M. R., Gomes, T., Chadha, R., Hawley, P. H., & McCracken, R. (2025) · medRxiv · doi:10.1101/2025.03.14.25323994
King, A. C., Zahrai, A., Bisson, E. J., Shergill, Y., Rice, D. B., Wai, E. K., Nedden, N. Z., Cooper, L., James, D. J., Rash, J. A., et al. (2025) · Digital Health · doi:10.1177/20552076251326229
Self-citationOpioid-induced neurotoxicity and delirium in the emergency department
Fischer, L. (2025) · Canadian Journal of Emergency Medicine · doi:10.1007/s43678-024-00816-y
“The recommended dose of opioid to administer is 10% of this calculation [5].”
Patel, M. M., Shing, D. Y., George, A., Bhaskaran, D., Atalian, A., Walia, M., Patel, M., Tushinski, D. M., Adili, A. F., Bali, K., et al. (2025) · Cureus · doi:10.7759/cureus.83977
“The absolute risk of non-fatal opioid overdose is 0.2%, and the risk of death is 0.1% following prescription for chronic pain; also, a prior focus group study of pain patients found that they placed little importance on the small likelihood of accidental overdose or death [33,34].”
InfluentialSelf-citationElectronic consultation questions asked to addiction medicine specialists by primary care providers
Chan, C., Zhu, G., Liddy, C. E., Myran, D. T., Keely, E., & Radhakrishnan, A. (2025) · Canadian Family Physician · doi:10.46747/cfp.7105e82
“30,31 This context likely contributes to the volume of eConsults sent to addiction medicine inquiring about chronic pain management, even for patients where opioid use disorder has not been diagnosed.”
Cheon, S., Choi, S.-Y., Kim, K. R., Choi, H., & Chung, J. E. (2025) · JMIR Public Health and Surveillance · doi:10.2196/63960
Hemstock, R., McRae, S. M. B., Laxdal, I., Mutter, T. C., Friesen, K. J., Prior, H. J., Old, J., Stranges, G. A., Lemmex, D. B., Dubberley, J., et al. (2025) · Canadian Journal of Surgery · doi:10.1503/cjs.000325
Hayward, J., Li, H., Holodinsky, J. K., Dong, K. A., & Innes, G. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5352431
Holton, A. E., Wang, T., Hamzat, B., Bragg, S., deGonzague, B., Mecredy, G. C., Campbell, T. J., Antoniou, T., McGregor, L., Bertram, J., et al. (2025) · Canadian Journal of Public Health · doi:10.17269/s41997-025-01097-3
“…the risks of iatrogenic opioid-related harm, prescribing guidelines recommend reserving these drugs for cases where other options have been ineffective, using the lowest effective dose and avoiding concurrent use of other respiratory depressants, such as benzodiazepines (Busse et al., 2017).”
Patel, M., Parnian, P., Madden, K., Sprague, S., Acai, A., Kleinlugtenbelt, Y. V., Saka, N., Landman, E. B. M., Shanthanna, H., Khanna, V., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331335
Self-citationMcGennis, M.-È., Gagnon, M., Paquet, J., Turgeon, A. F., Macedo, T., Côté, C. L., Matina, M. K., Verret, M., Moore, L., Richard‐Denis, A., et al. (2025) · Neurotrauma Reports · doi:10.1177/08977151251365585
Unseen layers of risk in long-term opioid therapy demand broader surveillance metrics
Chen, C., & Chen, S. (2025) · Pain · doi:10.1097/j.pain.0000000000003740
Pain medication associated with decreased physical performance and rehabilitation progress
Fernandes, L. M., Vuistiner, P., Burrus, C., Konzelmann, M., Léger, B., Besson, M. J., & Lüthi, F. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001323
Response to: Revisiting Opioid Risk Assessment
Jani, M., Girard, N., Bates, D. W., Buckeridge, D. L., Dixon, W. G., & Tamblyn, R. M. (2025) · Pain · doi:10.1097/j.pain.0000000000003792
Pharmacologic and Clinical Considerations of Morphine
Kataria, S., Roberts, C. J., Dupaquier, M. M., Arya, P., Sharpe, M., Shekoohi, S., & Kaye, A. D. (2025) · Springer eBooks · doi:10.1007/978-3-032-07407-2_7
Guan, Q., Hogan, M., Calzavara, A. J., McCormack, D., Lofters, A., Patel, T., Hitzig, S. L., Packer, T. L., & Guilcher, S. J. T. (2025) · Spinal Cord · doi:10.1038/s41393-025-01140-7
Opioid Initiation in Older Patients with Chronic Pain Who Received Authorized Cannabis Prescription
Fontaine, E., El-Mourad, J., Dubois, C., Eurich, D. T., Dyck, J. R. B., Hanlon, J. G., & Zongo, A. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2586250
“Among the pharmacological options for the treatment of chronic pain, opioids are prescribed when pain is not adequately controlled with non-opioid medications (Busse et al., 2017; Dowell & Haegerich, 2016).”
Emary, P. C., Corcoran, K. L., Coleman, B. C., Brown, A. L., Ciraco, C., DiDonato, J., Wang, L., Couban, R., Sud, A., & Busse, J. W. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001374
“16,30,33 However, because the current evidence informing the impact of chiropractic care on new or continued prescription opioid use for noncancer spine pain is only of very low certainty, rigorously designed RCTs are needed to confirm these findings.”
InfluentialSelf-citationHamina, A., Muller, A. E., Clausen, T., Skurtveit, S., Hesse, M., Tjagvad, C., Thylstrup, B., Odsbu, I., Zoega, H., Jónsdóttir, H. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19778154
Additional file 5 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274116
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659339
Additional file 6 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274119
Schrader, N. F., Niemann, A., Weitzel, M., Speckemeier, C., Abels, C., Blase, N., Giebel, G. D., Riederer, C., Nadstawek, J., Straßmeir, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123668
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659336
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659333
Schrader, N. F., Niemann, A., Weitzel, M., Speckemeier, C., Abels, C., Blase, N., Giebel, G. D., Riederer, C., Nadstawek, J., Straßmeir, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123662
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659342
Sud, A., Doukas, K., Hodgson, K., Hsu, J., Miatello, A., Moineddin, R., & Paton, M. (2021) · Figshare · doi:10.6084/m9.figshare.13978855
Additional file 4 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274113
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659348
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659330
Schrader, N. F., Niemann, A., Weitzel, M., Speckemeier, C., Abels, C., Blase, N., Giebel, G. D., Riederer, C., Nadstawek, J., Straßmeir, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123665
Smylie, J. K., Rotondi, M. A., Filipenko, S., Cox, W. T. L., Smylie, D., Ward, C. L., Klopfer, K., Lofters, A., O’Neill, B., Graham, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659345
Additional file 2 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274107
Peri, K., Honeycutt, L., Wennberg, E., Windle, S. B., Filion, K. B., Gore, G., Kudrina, I., Paraskevopoulos, E., Moiz, A., Martel, M. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26683201
Peri, K., Honeycutt, L., Wennberg, E., Windle, S. B., Filion, K. B., Gore, G., Kudrina, I., Paraskevopoulos, E., Moiz, A., Martel, M. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26683198
Additional file 3 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274110
Thille, P., Tobin, A., Evans, J. M., Katz, A., & Russell, G. M. (2024) · Figshare · doi:10.6084/m9.figshare.26500350
Sud, A., Doukas, K., Hodgson, K., Hsu, J., Miatello, A., Moineddin, R., & Paton, M. (2021) · Figshare · doi:10.6084/m9.figshare.13978861
Additional file 1 of Eye acupuncture for pain conditions: a scoping review of clinical studies
Chi, Y., Barth, J., Wang, M., Robinson, N., Li, Z.-H., & Liu, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14274104
Clinical Application Progress of Acetaminophen Oxycodone
王, 佳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123653
Davis, C. N., Lee, Y.-J., & Cheatle, M. D. (2025) · Pain Medicine · doi:10.1093/pm/pnaf161
Albert, C. A., & Sarver, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-10403-8_5
Chronic Non-cancer Pain Assessment
Mayo, P., Walter, S., & Zhao, X. W. C. (2025) · Springer eBooks · doi:10.1007/978-3-032-10050-4_23
Pharmacological and rehabilitation strategies in opioid-induced constipation: an observational study
Caramma, S., Condorelli, R., Buccheri, E., Maria, M., Rosta, G., Longo, L., Gotti, F. L., Brundo, S., & Chiaramonte, R. (2026) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2026.1683677
Continuity of Primary Care and Delayed Opioid Initiation in Non‐Cancer Pain: A Cohort Study
Jo, A. J., Choo, E., Kim, S., Je, N. K., & Lee, I. (2026) · European Journal of Pain · doi:10.1002/ejp.70226
“Although opioids remain an essential option for severe and cancer-related pain, their long-term use in non-cancer pain (NCP) is associated with limited effectiveness and a substantial risk of dependence, misuse and overdose (Busse et al. 2017; Els et al. 2023).”
Windsor, N. D., & Smith, B. (2026) · Journal of Opioid Management · doi:10.5055/jom.0974
Jung, M., Xia, T., Picco, L., Lubman, D. I., Lalic, S., Pearce, C. M., Buchbinder, R., Rowland, B., Andrew, N. E., Bell, J. S., et al. (2025) · Pain · doi:10.1097/j.pain.0000000000003852
“7,17,35,46 Our findings extend previous research by highlighting the risks of unintended mental health outcomes associated with large opioid dose reductions or discontinuing opioids.”
Hayward, J., Li, H., Holodinsky, J. K., Dong, K. A., & Innes, G. D. (2026) · Canadian Journal of Public Health · doi:10.17269/s41997-026-01182-1
Halpape, K., Jorgenson, D. J., & Rogers, M. (2026) · Canadian Journal of Pain · doi:10.1080/24740527.2026.2627924
Piotrowski, A., Schmidt, A., Kufeld, N., Kersting, C., Bencheva, V., Wiese, B., Bahrs, O., Hunger‐Schoppe, C., Maas, M., Preuss, J., et al. (2026) · Journal of Pain Research · doi:10.2147/jpr.s564795
“104,106 The fact that established pain guidelines do not yet address gender-sensitive care 8,61,66–71 suggests a potential gap in current clinical practice which the GESCO intervention aims to address.”
Godbout-Parent, M., Julien, N., Nguefack, H. L. N., Pagé, M. G., Guénette, L., Blais, L., Ménard, N., Beaudoın, S., & Lacasse, A. (2026) · Frontiers in Pain Research · doi:10.3389/fpain.2026.1810867 · Cited by 1
Is the Nonmedical Use of Prescription Opioids Making a Quiet “Comeback” in Canada?
Fischer, B., Jutras‐Aswad, D., & Foll, B. L. (2026) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000275
Gjorgjievski, M., Madden, K., Tushinski, D. M., Adili, A. F., Bullen, C., Koziarz, F., Koziarz, A., de Freitas, L., Li, S., Bhandari, M., et al. (2026) · Journal of International Medical Research · doi:10.1177/03000605261438343
Pandian, M. K., Kumar, A., Kantha, M., & Sridhar, M. R. (2026) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_1_26
Sharma, V., Li, W., Joon, T., Dubois, C., Lau, D., Jess, E., Lindeman, C., Kain, N. A., Ye, M., Semenchuk, M., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-103318
“25 Predictors and ML methods Similar to our previous work, all candidate predictors were obtained from the PIN dataset and were either derived from the literature 26 27 or directly incorporated from the data, unmodified (online supplemental etable 2).”
Lim, J., Tope, P., Schaefer, M., Williams, I., Farhat, I., Benedetti, A., & Panagiotoglou, D. (2026) · Canadian Journal of Pain · doi:10.1080/24740527.2026.2650299
Zhang, Y., Zhao, Y., Cheng, Y., Liu, L., Wang, Z., & Wu, B. (2026) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2026.102060
Xu, Z., Si, C., Dong, Y., Zhang, H., Zhang, J., Ge, W., & Wu, X. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03941-6
Brinkmöller, S., Poß-Doering, R., Straßner, C., & Laux, G. (2026) · Journal of Pain Research · doi:10.2147/jpr.s599161
Lyman, K., Choi, J., Jutras‐Aswad, D., Foll, B. L., Klaire, S. S., & Socias, M. E. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70190
Nurses’ Attitudes and Beliefs About Opioid Use in Pain Management: A Scoping Review
Suçeken, S., Taylan, S., & Aslan, F. E. (2026) · Pain Management Nursing · doi:10.1016/j.pmn.2026.05.024
Schoberer, D., Pock, E. M. L., Eglseer, D., & Hoedl, M. (2026) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2026.05.002
Bertin, C., Dupouy, J., Authier, N., Michenot, N., Verdier, S., Chappuy, M., & Trouvin, A. (2026) · Pain and Therapy · doi:10.1007/s40122-026-00852-9
“In pain management contexts, opioid titration should begin with the lowest effective dose appropriate to the clinical situation [23, 24, 41, 42].”
Chang, J. R., Zhang, Y., Zhang, Y., Lin, L. G., Hamoudi, H. J. A. S., Li, S. X., Chan, E. W., Runge, N., Saueressig, T., Singh, H., et al. (2026) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2026.102340
Saberian, L., Parmar, N., Lau, J., Dale, C., Sud, A., Hatcher, L., Carol, A., Mian, N., Bootsman, N., Selby, P. L., et al. (2026) · Canadian Journal of Pain · doi:10.1080/24740527.2026.2682926
Chronic pain and its treatment options
Kozák, Š. (2026) · Neurologie pro praxi · doi:10.36290/neu.2026.035
Time to Change Course: Persistent High-risk Extended-release Opioid Prescribing after Arthroplasty
Bayron, J., & Sutherland, T. N. (2026) · Anesthesiology · doi:10.1097/aln.0000000000006222
Molecular recognition of piperidine derivatives as MOR modulators
Naseem, H., Mushtaq, N., & Ul‐Haq, Z. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100499
Metadata
- Authors
- Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J., Agoritsas, T., Akl, E. A., Carrasco-Labra, A., Cooper, L., Cull, C., da Costa, B. R., Frank, J. W., Grant, G., Iorio, A., Persaud, N., Stern, S., Tugwell, P., Vandvik, P. O., & Guyatt, G. H.
- Affiliations
- University of Bern (CH)
- ORCID
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Impact Inc.
- Published
- 2017-05-07
- Volume
- 189
- Issue
- 18
- Pages
- E659-E666
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- PMC
- PMC5422149
- OpenAlex
- W2612284626
- Cited by
- 707
- References
- 50
- Citations by year
- 2026: 37 · 2025: 58 · 2024: 71 · 2023: 59 · 2022: 82 · 2021: 107 · 2020: 105 · 2019: 86 · 2018: 67 · 2017: 29
- FWCI
- 73.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Medical Association Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK2 HX001914)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid therapy, chronic non-cancer pain, pain management, opioid prescribing
- MeSH terms
- Analgesics, Opioid, Dose-Response Relationship, Drug, Humans, Opioid-Related Disorders, Pain Measurement, Primary Health Care, Treatment Outcome, Drug Monitoring, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review